14-3-3 Sigma isoform interacts with the cytoplasmic domain of the transmembrane BP180 in keratinocytes

Journal of Cellular Physiology

Volumn 212, Issue 3, 2007, Pages 675-681

  Li, Yunyuan ^a   Lin, Xiaoyue ^a   Kilani, Ruhangiz T ^b   Jones, Jonathan C R ^c   Ghahary, Aziz ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6 INTEGRIN; BETA4 INTEGRIN; BULLOUS PEMPHIGOID ANTIGEN 1; COLLAGEN TYPE 17; PROTEIN 14 3 3; PROTEIN 14 3 3 SIGMA; PROTEIN BP180; STRATIFIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; DIMERIZATION; EPIDERMIS; EPITHELIUM CELL; HEMIDESMOSOME; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION;

AUTOANTIGENS; CELL MEMBRANE; CELLS, CULTURED; CYTOPLASM; DIMERIZATION; EXONUCLEASES; HUMANS; IMMUNOPRECIPITATION; KERATINOCYTES; MOLECULAR WEIGHT; MUTATION; NEOPLASM PROTEINS; NON-FIBRILLAR COLLAGENS; PEPTIDE FRAGMENTS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EUKARYOTA;

EID: 34547936544     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21064     Document Type: Article

References (36)

1. Aho S, Uitto J. 1999. 180-kD bullous pemphigoid antigen/type XVII collagen: tissue-specific expression and molecular interactions with keratin 18. J Cell Biochem 72:356-367.
2. Balding SD, Prost C, Diaz LA, Bernard P, Bedane C, Aberdam D, Giudice GJ. 1996. Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol 106:141-146.
3. Borradori L, Koch PJ, Niessen CM, Erkeland S, van Leusden MR, Sonnenberg A. 1997. The localization of bullous pemphigoid antigen 180 (BP180) in hemidesmosomes is mediated by its cytoplasmic domain and seems to be regulated by the beta4 integrin subunit. J Cell Biol 136:1333-1347.
4. Braselmann C, McCormick F. 1995. Bcr and Raf form a complex in vivo via 14-3-proteins. EMBO J 14:4839-4848.
5. Cotelle V, Meek SE, Provan F, Milne FC, Morrice N, MacKintosh C. 2000. 14-3-3s regulate global cleavage of their diverse binding partners in sugar-starved Arabidopsis cells. EMBO J 19:2869-2876.
6. Fairley JA, Heintz PW, Neuburg M, Diaz LA, Giudice GJ. 1995. Expression pattern of the bullous pemphigoid-180 antigen in normal and neoplastic epithelia. Br J Dermatol 133:385-391.
7. Fu H, Subramanian RR, Masters SC. 2000. 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol40:617-647.
8. Ghahary A, Karimi-Busheri F, Marcoux Y, Li Y, Tredget EE, Kilani RT, Li L, Zheng J, Karami A, Keller BO, Weinfeld M. 2004. Keratinocyte-releasable stratifin functions as a potent collagenase-stimulating factor in fibroblasts. J Invest Dermatol 122:1188-1197.
9. Giudice GJ, Emery DJ, Diaz L. 1992. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 99:243-250.
10. Hirako Y, Owaribe K. 1998. Hemidesmosomes and their unique transmembrane protein BP180. Microscy Res Tech 43:207-217.
11. Hirako Y, Usukura J, Uematsu J, Hashimoto T, Kitajima Y, Owaribe K. 1998. Cleavage of BP180, a 180-kDa bullous pemphigoid antigen, yields a 120-kDa collagenous extracellular polypeptide. J Biol Chem 273:9711-9717.
12. Hopkinson SB, Jones JCR. 2000. The N terminus of the transmembrane protein BP180 interacts with the N-terminal domain of BP230, thereby mediating keratin cytoskeleton anchorage to the cell surface at the site of the hemidesmosome. Mol Biol Cell 11:277-286.
13. Hopkinson SB, Riddelle KS, Jones JCR. 1992. Cytoplasmic domain of the 180-kD bullous pemphigoid antigen, a hemidesmosomal component: molecular and cell biologic characterization. J Invest Dermatol 99:264-270.
14. Katz AB, Taichman LB. 1999. A partial catalog of proteins secreted by epidermal keratinocytes in culture. J Invest Dermatol 112:818-821.
15. Kitajima Y, Owaribe K, Nishizawa Y, Jokura Y, Yaoita H. 1992. Phorbol ester- and calcium-induced reorganization of 180-kDa bullous pemphigoid antigen on the ventral surface of cultured human keratinocytes as studied by immunofluorescence and immunoelectron microscopy. Exp Cell Res 203:17-24.
16. Kitajima Y, Owada MK, Fujisawa Y, Seishima M, Yaoita H, Hirako Y, Owaribe K. 1995. A hemidesmosomal transmembrane collagenous molecule, the 180-kDa bullous pemphigoid antigen (BPA II), is phosphorylated with 12-O- tetradecanoylphorbol-13-acetate in a human squamous cell carcinoma cell line (DJM-1). Epithelial Cell Biol 4:70-75.
17. Koster J, Geerts D, Favre B, Borradori L, Sonnenberg A. 2003. Analysis of the interactions between BP180, BP230, plectin and the integrin alpha6beta4 important for hemidesmosome assembly. J Cell Sci 116:387-399.
18. Lam E, Kilani RT, Li Y, Tredget EE, Ghahary A. 2005. Stratifin-induced matrix metalloproteinase-1 in fibroblast is mediated by c-fos and p38 mitogen-activated protein kinase activation. J Invest Dermatol 125:230-238.
19. Li K, Tamai K, Tan EM, Uitto J. 1993. Cloning of type XVII collagen. Complementary and genomic DNA sequences of mouse 180-kilodalton bullous pemphigoid antigen (BPAG2) predict an interrupted collagenous domain, a transmembrane segment, and unusual features in the 5′-end of the gene and the 3′-untranslated region of the mRNA. J Biol Chem 268:8825-8834.
20. Liao J, Omary MB. 1996. 14-3-3 proteins associate with phosphorylated simple epithelial keratins during cell cycle progression and act as a solubility cofactor. J Cell Biol 133:345-357.
21. Liu Z, Diaz LA, Troy JL, Taylor A, Emery DJ, Fairley JA, Giudice GJ. 1993. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 92:2480-2488.
22. Liu D, Bienkowska J, Petosa C, Collier RJ, Fu H, Liddington R. 1995. Crystal structure of the zeta isoform of the 14-3-protein. Nature (London) 376:191-194.
23. McGrath JA, Darling T, Gatalica B, Pohla-Gubo G, Hintner H, Christiano AM, Yancey K, Uitto J. 1996. A homozygous deletion mutation in the gene encoding the 180-kDa bullous pemphigoid antigen (BPAG2) in a family with generalized atrophic benign epidermolysis bullosa. J Invest Dermatol 106:771-774.
24. Muslin AJ, Tanner JW, Allen PM, Shaw AS. 1996. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell 84:889-897.
25. Payne J, Gong H, Trinkaus-Randall V. 2000. Tyrosine phosphorylation: a critical component in the formation of hemidesmosomes. Cell Tissue Res 300:401-411.
26. Santoro MM, Gaudino G, Marchisio PC. 2003. The MSP receptor regulates alpha6beta4 and alpha3beta1 integrins via 14-3-3 proteins in keratinocyte migration. Develop Cell 5:257-271.
27. Schacke H, Schumann H, Hammami-Hauasli N, Raghunath M, Bruckner-tuderman L. 1998. Two forms of collagen XVII in keratinocytes. A full-length transmembrane protein and a soluble ectodomain. J Biol Chem 273:25937-25943.
28. Schmidt E, Reimer S, Kruse N, Jainta S, Brocker EB, Marinkovich M, Giudic GJ, Zillikens D. 2000. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. J Invest Dermatol 115:842-848.
29. Schmidt E, Wehr B, Tabengwa EM, Seimer S, Brocker EB, Zillikens D. 2004. Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes. Clin Exp Immunol 135:497-504.
30. Shevchenko A, Wilm M, Vorm O, Mann M. 1996. Mass spectrometry sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 68:850-858.
31. Van den Bergh F, Giudice GJ. 2003. BP180 (type XVII collagen) and its role in cutaneous biology and disease. Adv Dermatol 19:37-71.
32. Van der Hoeven PCJ, Van der Wal JCM, Ruurs P, Van Dijk MCM, Van Blitterswijk WJ. 2000. 14-3-3 isotypes facilitate coupling of protein kinase C-zeta to Raf-1: negative regulation by 14-3-phosphorylation. Biochem J 345:297-306.
33. Vincenz C, Dixit VM. 1996. 14-3-3 proteins associate with A20 in an isoform-specific manner and function both as chaperone and adapter molecules. J Biol Chem 271:20029-20034.
34. Xiao B, Smerdon SJ, Jones DH, Dodson GG, Soneji Y, Aitken A, Gamblin SJ. 1995. Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways. Nature (London) 376:188-191.
35. Yaffe MB, Rittinger K, Volinia S, Caron PR, Aitken A, Leffers H, Gamblin SJ, Serdon SJ, Cantley LC. 1997. The structural basis for 14-3-3: phosphopeptide binding specificity. Cell 91:961-971.
36. Zillikens D. 1999. Acquired skin disease of hemidesmosomes. Dermatol Sci 20:134-154.